Grupo Supervielle (SUPV) officer discloses 245,441-share stock option grant
Rhea-AI Filing Summary
Grupo Supervielle S.A. officer Bruno Jesus Arcucci filed an initial Form 3 reporting a stock option award. The options give the right to buy 245,441 Class B ordinary shares at an exercise price of 1.1480 per share, expiring on October 1, 2032. According to the award terms, the grant vests over four years: 10% on December 31, 2026, 20% on December 31, 2027, 30% on December 31, 2028, and 40% on December 31, 2029. This filing records existing derivative holdings rather than a new market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Arcucci Bruno Jesus
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Stock Options (Right to Buy) — 245,441 shares (Direct)
Footnotes (1)
- F1. Reflects an option award granted in the form of Class B Ordinary Shares of the Issuer that vests as follows: 10% on December 31, 2026; 20% on December 31, 2027; 30% on December 31, 2028, and 40% on December 31, 2029.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the SUPV Form 3 filing by Bruno Jesus Arcucci report?
The Form 3 shows Bruno Jesus Arcucci’s initial beneficial ownership in Grupo Supervielle. It reports a stock option award over 245,441 Class B ordinary shares, establishing his existing derivative position rather than recording a new market transaction.
What is the exercise price and expiration date of Arcucci’s SUPV options?
The options have an exercise price of 1.1480 per underlying Class B ordinary share and expire on October 1, 2032. These terms define the price Arcucci would pay per share and the final date he can exercise the award.
How does the vesting schedule work for Arcucci’s Grupo Supervielle option award?
The award vests in four stages: 10% on December 31, 2026; 20% on December 31, 2027; 30% on December 31, 2028; and 40% on December 31, 2029. Arcucci gains exercisable rights to portions of the options at each vesting date.